《美股業績》財險股旅行家集團(TRV.US)季績勝預期 災難險損失按年升57%
道指成分股,美國財險股旅行家集團(Travelers)(TRV.US)公布第二季度業績。季度淨利潤5.51億美元,按年跌41%。每股季度攤薄純利2.27美元,經調整後為2.57美元,高於市場預期的1.97美元。季度淨保費收益按年升11%至90.2億美元,總收入按年升5%至91.36億美元。
公司稅前淨投資收益按年跌14%至7.07億美元,季內錄得扣除再保的災難險損失達7.46億美元,按年升57%,主要受美國出現冰雹及強風吹襲影響。季內綜合成本率為98.3%,按年升3個百分點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.